New Publication Describes Positive Patient Experience in Study of Ocular Therapeutix' DEXTENZA™ Following Cataract Surgery
TMCnet.com,
] Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development, manufacturing and…